MEDNAX (MD) EPS Estimated At $0.79; 10 Analysts Are Bullish TransDigm Group (TDG) Last Week

October 12, 2017 - By Marie Mckinney

Among 18 analysts covering Transdigm Group Incorporated (NYSE:TDG), 10 have Buy rating, 1 Sell and 7 Hold. Therefore 56% are positive. Transdigm Group Incorporated had 55 analyst reports since August 4, 2015 according to SRatingsIntel. Canaccord Genuity maintained the shares of TDG in report on Friday, May 26 with “Buy” rating. The rating was downgraded by Jefferies on Wednesday, September 20 to “Hold”. The rating was initiated by Robert W. Baird with “Outperform” on Thursday, October 6. The stock of TransDigm Group Incorporated (NYSE:TDG) has “Buy” rating given on Wednesday, September 13 by Canaccord Genuity. Cowen & Co downgraded the shares of TDG in report on Thursday, March 23 to “Market Perform” rating. The company was initiated on Thursday, September 22 by Jefferies. The stock has “Hold” rating by Zacks on Wednesday, August 26. RBC Capital Markets maintained the stock with “Buy” rating in Friday, September 1 report. KeyBanc Capital Markets downgraded TransDigm Group Incorporated (NYSE:TDG) on Wednesday, April 13 to “Sector Weight” rating. The rating was maintained by Robert W. Baird with “Buy” on Tuesday, June 6. See TransDigm Group Incorporated (NYSE:TDG) latest ratings:

06/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $316.0 Maintain
20/09/2017 Broker: Jefferies Rating: Hold New Target: $280.0 Downgrade
13/09/2017 Broker: Canaccord Genuity Rating: Buy New Target: $330.0 Maintain
05/09/2017 Broker: Jefferies Rating: Buy New Target: $322.0 Maintain
01/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $316.0 Maintain
23/08/2017 Broker: Robert W. Baird Rating: Buy New Target: $300.0 Maintain
10/08/2017 Broker: Credit Suisse Rating: Buy New Target: $320.0000 Maintain
09/08/2017 Broker: Deutsche Bank Rating: Buy Old Target: $305 New Target: $320 Maintain
09/08/2017 Broker: Canaccord Genuity Rating: Buy New Target: $330.0000 Maintain
08/08/2017 Broker: Cowen & Co Rating: Hold New Target: $219.0000 Maintain

Analysts expect MEDNAX Inc (NYSE:MD) to report $0.79 EPS on October, 26.They anticipate $0.28 EPS change or 26.17% from last quarter’s $1.07 EPS. MD’s profit would be $74.31 million giving it 13.49 P/E if the $0.79 EPS is correct. After having $0.80 EPS previously, MEDNAX Inc’s analysts see -1.25% EPS growth. About 132,355 shares traded. MEDNAX Inc (NYSE:MD) has declined 18.20% since October 12, 2016 and is downtrending. It has underperformed by 34.90% the S&P500.

Since June 12, 2017, it had 0 buys, and 1 insider sale for $1.59 million activity. Valladares Jorge sold $1.59 million worth of stock or 6,000 shares.

Investors sentiment decreased to 0.63 in Q2 2017. Its down 0.45, from 1.08 in 2017Q1. It dropped, as 46 investors sold TransDigm Group Incorporated shares while 159 reduced holdings. 39 funds opened positions while 91 raised stakes. 57.61 million shares or 0.47% less from 57.88 million shares in 2017Q1 were reported. Marble Arch Limited Partnership holds 6.45% or 342,000 shares. Tesuji Partners Lc owns 21.05% invested in TransDigm Group Incorporated (NYSE:TDG) for 749,664 shares. Airain holds 5,886 shares. Commonwealth Of Pennsylvania Public School Empls Retrmt Systems holds 0.01% of its portfolio in TransDigm Group Incorporated (NYSE:TDG) for 3,633 shares. Colony Grp Inc holds 0.16% or 8,135 shares. Millennium Ltd Co has invested 0% in TransDigm Group Incorporated (NYSE:TDG). Intl Ca has 21,450 shares for 0.82% of their portfolio. 84 are owned by Whittier Of Nevada. Rockefeller Financial Service Inc reported 244 shares. 108 are owned by Acadian Asset Mgmt Limited Liability Corporation. Lmr Prtnrs Llp, a United Kingdom-based fund reported 5,600 shares. Prudential Public Limited Liability, Illinois-based fund reported 1,700 shares. Credit Suisse Ag invested 0.05% of its portfolio in TransDigm Group Incorporated (NYSE:TDG). Advisors Asset Mngmt reported 16,724 shares stake. California Public Employees Retirement reported 93,700 shares.

TransDigm Group Incorporated is a designer, producer and supplier of engineered aircraft components for use on commercial and military aircraft in service. The company has market cap of $13.68 billion. The Firm operates through three divisions: Power & Control, Airframe and Non-aviation. It has a 27.25 P/E ratio. The Power & Control segment includes activities that primarily develop, produce and market systems and components that provide power to or control power of the aircraft utilizing electronic, fluid, power and mechanical motion control technologies.

About 19,736 shares traded. TransDigm Group Incorporated (NYSE:TDG) has risen 12.77% since October 12, 2016 and is uptrending. It has underperformed by 3.93% the S&P500.

Among 14 analysts covering MEDNAX (NYSE:MD), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. MEDNAX had 34 analyst reports since July 31, 2015 according to SRatingsIntel. Robert W. Baird maintained it with “Hold” rating and $47.0 target in Thursday, October 5 report. The firm has “Hold” rating given on Thursday, May 25 by Stifel Nicolaus. The rating was maintained by Jefferies with “Hold” on Tuesday, April 11. The rating was initiated by JP Morgan on Wednesday, September 16 with “Overweight”. Mizuho maintained MEDNAX Inc (NYSE:MD) rating on Friday, April 29. Mizuho has “Buy” rating and $79 target. The rating was maintained by Robert W. Baird on Friday, September 1 with “Hold”. Mizuho initiated MEDNAX Inc (NYSE:MD) on Wednesday, September 30 with “Buy” rating. As per Tuesday, November 3, the company rating was maintained by Stifel Nicolaus. The firm earned “Neutral” rating on Tuesday, May 30 by Mizuho. The company was downgraded on Tuesday, December 13 by Jefferies.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The company has market cap of $4.01 billion. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital neonatal intensive care units , to babies born prematurely or with medical complications. It has a 13.55 P/E ratio. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com